3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase EARLY_PHASE1
1
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Breast Neoplasms
1
Interventions
Letrozole
9
Fluorodeoxyglucose F18
7
pembrolizumab
6
Magnetic Resonance Spectroscopy
6
atezolizumab
5
Blood Specimen Collection
5
Trastuzumab
4
Oncolytic Virotherapy
4
Biopsy
4
Bevacizumab
4
palbociclib
3
durvalumab
3
Vitamin D
3
Taxes
3
Saline Solution
3
Radiotherapy
3
Metformin
3
Fish Oils
3
Docosahexaenoic Acids
3
Denosumab
3
Carboplatin
3
Albumin-Bound Paclitaxel
3
pertuzumab
2
olaparib
2
bazedoxifene
2
Vinorelbine
2
Tamoxifen
2
Sentinel Lymph Node Biopsy
2
Positron-Emission Tomography
2
Positron Emission Tomography Computed Tomography
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
reolysin
×
Breast
×
Clear all
NCT04102618
2022-08-15
AWARE-1
Oncolytics Biotech
Phase EARLY_PHASE1
Terminated
26 enrolled